The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
- DOI
- 10.3389/fendo.2026.1822475
- Published
- 2026
- Container
- Frontiers in endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1822475,
title = {The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.},
author = {Dominikowski A and Rękoś Z and Olejarz M and Szczepanek-Parulska E and Domin R and RuchaŁa M},
year = {2026},
journal = {Frontiers in endocrinology},
doi = {10.3389/fendo.2026.1822475},
url = {https://doi.org/10.3389/fendo.2026.1822475}
}RIS
TY - JOUR TI - The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. AU - Dominikowski A AU - Rękoś Z AU - Olejarz M AU - Szczepanek-Parulska E AU - Domin R AU - RuchaŁa M PY - 2026 JO - Frontiers in endocrinology DO - 10.3389/fendo.2026.1822475 UR - https://doi.org/10.3389/fendo.2026.1822475 ER -
APA
A, D., Z, R., M, O., E, S., R, D., & M, R. (2026). The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1822475
Source records
- pubmed · retrieved 2026-09-26T21:48:51.811Z